Known targets — ChEMBL curated mechanism
ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2
The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 known ✓ | P25103 | 3/20 | 0.58 |
| ▸ | TACR2 | P21452 | 14/20 | 0.58 |
| ▸ | TACR3 | P29371 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL8940285 | 0.94 | TACR2 (0.57) | TACR2TACR1TACR3 | |
| Citric Acid SCHEMBL8940363 | 0.94 | TACR2 (0.57) | TACR2TACR1TACR3 | |
| Citric Acid SCHEMBL8940461 | 0.94 | TACR2 (0.62) | TACR2TACR1TACR3 | |
| SCHEMBL8301140 | 0.94 | TACR2 (0.66) | TACR2TACR1TACR3 | |
| SCHEMBL8828923 | 0.94 | TACR2 (0.66) | TACR2TACR1TACR3 | |
| Citric Acid SCHEMBL9046988 | 0.93 | TACR2 (0.56) | TACR2TACR1TACR3 | |
| Citric Acid SCHEMBL8940423 | 0.92 | TACR2 (0.59) | TACR2TACR1TACR3 | |
| Citric Acid SCHEMBL8940410 | 0.92 | TACR2 (0.60) | TACR2TACR1TACR3 | |
| Citric Acid SCHEMBL8940339 | 0.92 | TACR2 (0.60) | TACR2TACR1TACR3 | |
| Citric Acid SCHEMBL8940305 | 0.92 | TACR2 (0.55) | TACR2TACR1TACR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0726893-A1 | NOVEL 4-PIPERIDINYL SUBSTITUTED LACTAMES AS NEUROKININ 2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ASTHMA | ZENECA LIMITED (GB) | 1996-08-21 | — | — | EP | disclosed |
| US-5534525-A | Lactam derivatives | ZENECA LIMITED (GB) | 1996-07-09 | — | — | US | disclosed |
| WO-1995012577-A1 | NOVEL 4-PIPERIDINYL SUBSTITUTED LACTAMES AS NEUROKININ 2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ASTHMA | ZENECA LIMITED (GB) | 1995-05-11 | — | — | WO | disclosed |